CYTO Innovation Live Technology Showcase & Panel

Recorded On: 08/05/2020

8:45 - 9:00am
Welcome back to CYTO Virtual 2020!

President's Welcome
Jonni Moore, PhD, Professor of Pathology and Laboratory Medicine; Faculty Director, Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource Laboratory; Executive Director, PathBioresource, Perelman School of Medicine of the University of Pennsylvania

Master of Ceremonies Welcome
Nicole Poulton, PhD, Director, Center for Aquatic Cytometry, Bigelow Laboratory for Ocean Sciences
Pratip Chattopadhyay, PhD, Associate Professor of Pathology; Director, Precision Immunology Incubator, Isaac and Laura Perlmutter Cancer Center, NYU-Langone Medical Center

9:00 - 10:00am
CYTO Innovation Technology Showcase

This year's CYTO Innovation Technology Showcase finalists will be selected based on panel judging and audience feedback during a one week pre-CYTO preview period. Each Finalist will present their pitch followed by five minutes of questioning by our Showcase panel regarding the market need, the technological innovation, and the commercialization strategy. Following the Showcase the panel will select one winner, to be announced later in the day.

Agenda and Speakers

Session Moderator
John Nolan, PhD, Professor, Scintillon Institute

Showcase Finalists
Andrea Wang, Co-founder & CEO, AHEAD Medicine
Janette Phi, MBA, CCO, Applied Cells
Steve, Tokarz, MBA, CEO, StabiLux Biosciences

Panelists
Diether Recktenwald, PhD, Principal, Desatoya LLC, VP Advanced Technology, (Retired) BD Biosciences
Bill Hyun, MS, PhD, Venture Partner, Genoa Ventures
Elena Holden, MD, President and CEO, Tomocube USA, Inc.

Jonni Moore, PhD (Moderator)

Professor of Pathology and Laboratory Medicine; Faculty Director, Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource Laboratory; Executive Director, PathBioresource, Perelman School of Medicine of the University of Pennsylvania

Jonni Moore, Ph.D. is a Professor of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania, Scientific Director of the Abramson Cancer Center Flow Cytometry and Cell Sorting Shared Resource, and Emeritus Director, Founder, and currently Senior Advisor of the Clinical Flow Cytometry Laboratory at the Hospital of the University of Pennsylvania. She is currently the President of ISAC.  She received her PhD from Thomas Jefferson University in Philadelphia in Microbiology and completed a postdoc with Peter Nowell, MD at the University of Pennsylvania.

Nicole Poulton, PhD (Moderator)

Director, Center for Aquatic Cytometry, Bigelow Laboratory for Ocean Sciences

Dr. Nicole Poulton is the Director of the Center for Aquatic Cytometry, and a Research Scientist at Bigelow Laboratory for Ocean Sciences.  Nicole’s main research interests focus on phytoplankton and aquatic microbial ecology, including harmful algal blooms and the role of phytoplankton in the global carbon cycle.  Her research uses aquatic flow and imaging cytometry, single cell sorting and genomics to examine phytoplankton and bacterioplankton in the oceanic environment.   She has over 25 years of flow cytometric experience within the aquatic sciences. Nicole received her PhD in Biological Oceanography from the Massachusetts Institute of Technology and Woods Hole Oceanographic Institution.  She joined Bigelow Laboratory as a Research Scientist in 2008 and became the Director of the Center for Aquatic Cytometry in 2014.  Nicole is very active in education and outreach and is also an ISAC Shared Resource Laboratory Emerging Leader (2017-2021).

Pratip Chattopadhyay, PhD (Moderator)

Associate Professor of Pathology; Director, Precision Immunology Incubator, Isaac and Laura Perlmutter Cancer Center, NYU-Langone Medical Center

Pratip Chattopadhyay, PhD is an Associate Professor (Pathology) and founding Director of NYU Langone Health’s Precision Immunology Laboratory (PIL). His laboratory performs independent research in tumor immunology and provides cutting-edge immune monitoring services for a wide variety of biomedical disciplines (cancer, infectious disease, rheumatology). We use high parameter cytometry technologies, including 30-parameter flow cytometry and combined protein/mRNA analysis by RNA sequencing (molecular cytometry), to reveal biomarkers that predict patient outcomes, better understand disease pathogenesis, and inform rational design of combination drug therapies.

John Nolan, PhD (Moderator)

Panelist

Professor & Principal Investigator, Scintillon Institute 

John Nolan is a Professor at The Scintillon Institute, where his research group develops and applies new technologies for cytometry. Current projects in his lab are focused on spectral flow cytometry, single nanoparticle particle analysis, and the biology and applications of extracellular vesicles (EVs). He is on the Editorial Boards of Cytometry and Current Protocols in Cytometry, a Fellow of the American Institute of Medical and Biological Engineering (AIMBE), and a Past President of ISAC.

Diether Recktenwald, PhD

Panelist

Principal, Desatoya LLC; VP Adv. Technology (Retired), BD Biosciences

Dr. Recktenwald currently supports academic and industrial teams at Desatoya LLC with his expertise in technology transfer in the field of cytometry. He worked until October of 2012 as VP of Advanced Technology on the identification and evaluation of novel technologies for new cell analysis products at BD Biosciences. Starting in 1981, his group at BD developed the technology for multi-color fluorescence reagent-, instrument- and software-systems for flow cytometry. In 1993 fluorescence detection with single molecule sensitivity was demonstrated by his group using CCD based fluorescence microscopy. As VP R&D of AmCell Corporation from 1994 to 1998, in collaboration with Amgen, he was responsible for leading the development and documentation of the CliniMACSTM system for hematopoietic progenitor cell purification for cell therapy with regulatory clearance in Europe and the US. As VP R&D for BD Biosciences Immunocytometry Systems from 2002 to 2004, he led the completion of the development of several new flow cytometry systems (i.e FACSAria, FACSArray, LSR-II, FACSCanto) and accessories (i.e SPA, LWA). In 2004 he was appointed VP Advanced Technology for BD Biosciences to identify relevant technologies and to integrate them to grow the Biosciences business. Dr. Recktenwald is a BD fellow emeritus and recipient of the 2017 ISAC Distinguished Service Award.

Elena Holden, MD

President and CEO, Tomocube USA, Inc.

Dr. Holden’s area of expertise and interests are in advancing the commercialization of breakthrough developments in cancer cell biology, personalized biomarkers of disease progression and therapy together with the implementation of imaging cytometry systems for cell-based analyses. During her career she led multi-functional teams as Chief Strategic Marketing at Thorlabs, President and CEO of Compucyte Corporation, and Business Development Manager/Regional Director at Chiron Diagnostics. Today Elena leads development and commercialization of IDV products as President and CEO, Tomocube USA, Inc. and Chief Strategy Officer, TomoCube, South Korea. She is also an Associate Editor of the Cytometry Part A, the official journal of ISAC and a committee member of the SPIE/ Photonics West Quantitative Phase Imaging.

Bill Hyun, PhD, MS

Panelist

Venture Partner, Genoa Ventures

With more than 25 years of life technology experience, William (Bill) Hyun is a respected expert in both basic research and clinical lab technology development. At the University of California San Francisco, Bill directed one of the largest academic core facilities in the world with a strong concentration on cytometry and genomic technologies implementing a myriad of research, translational and clinical applications. His academic career included joint appointments at UC Berkeley and the Lawrence Berkeley National Lab, three honorary doctorates, and authorship of over 100 peer-reviewed publications. Bill has been directly involved in the conception, design, engineering and validation of numerous commercially successful analytical instruments, consumable products, and software programs, often in collaboration with companies like Carl Zeiss, Becton Dickinson, and Sony Corp.

Steve Tokarz, MBA

CEO-In-Residence, NovoLux

Yoke Khin Yap, PhD

President & CTO, NovoLux

Andrea Wang

Co-founder & CEO, AHEAD Medicine

Janette Phi, MBA

CMLE Credit: 1.0

Components visible upon registration.

NOTE: This event is held in Eastern Daylight time (GMT-4)